albenatide (CJC-1134-PC) / ConjuChem, Changshan Kaijiejian Biopharma 
Welcome,         Profile    Billing    Logout  
 5 Diseases   2 Trials   2 Trials   7 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albenatide (CJC-1134-PC) / ConjuChem, Changshan Kaijiejian Biopharma
ChiCTR-IPC-15007191: The randomized, double-blind, placebo-controlled anddose escalation I phase study evaluating the tolerence, pharmacokenetics andefficacy of single dose andescalating dose to target dose every week of CJC-1134- PC in healthy subjects

Not yet recruiting
1
10
 
CJC-1134-PC
The first hospital of Jilin University; Kaijiejian biophamaceutical co., LTD, Hebei, Kaijiejian biophamaceutical co., LTD,Hebei
type 2 diabetes
 
 
ChiCTR-IPC-15007190: The randomized, double-blind, placebo-controlled anddose escalation I phase study evaluating the safety, pharmacokenetics andefficacy of titration dose to target dose every week of CJC-1134- PC in type 2 diabetes subjects

Not yet recruiting
1
10
 
CJC-1134-PC
The first hospital of Jilin University; Kaijiejian biophamaceutical co., LTD, Hebei, Kaijiejian biophamaceutical co., LTD, Hebei
type 2 diabetes
 
 

Download Options